This informational website is developed by Chiesi USA, and is intended only residents of the United States.



The risk of life-threatening complications increases as iron builds up in the organs

Create infographic with copy below

60-70% of deaths in people with thalassemia major are due to heart complications and disease.

Create infographic with copy below

People with sickle cell disease receiving transfusions had 4.1 hospital stays per year vs. 2.1 for non-transfused patients.

The death rate is 3X higher among people with thalassemia major and sickle cell disease with transfusional iron overload.

Based on a total of 1,073 patients diagnosed with thalassemia major before the age of 3. Click here to read the full study.Based on a study of people who were either currently on or had received regular transfusion therapy and confirmed to have iron overload as defined by a liver iron concentration (LIC) of >10 mg/g dry weight or 3 serum ferritin values that averaged ≥2,000 ng/mL within the previous 12 months. 142 people with thalassemia and 199 people with sickle cell disease who received regular transfusions were included in the study group and 64 people with sickle cell disease who did not receive transfusions were selected as controls. Click here to read the full study.

Appropriate iron chelation, at the appropriate dosing level, removes extra iron from the body and organs to help prevent damage caused by iron overload

Goals of appropriate chelation therapy

VISUAL – FPO – to be recreated VISUAL – FPO – to be recreated VISUAL – FPO – to be recreated